Article
Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans.
The pharmacogenomics journal - 1 Feb 2008
Kimmel S E, Christie J, Kealey C, Chen Z, Price M, Thorn C F, Brensinger C M, Newcomb C W, Whitehead A S
Abstract excerpt
Warfarin sodium is a vitamin K antagonist that is plagued by large variability in patient response, including higher dose requirements among African Americans. Polymorphisms in the gene encoding apolipoprotein E (APOE) may partly explain this variability by altering transport of vitamin K to the liver. In a prospective cohort study of 232 individuals (52.2% Caucasian and 47.8% African American) initiating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
